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The HBx (hepatitis B virus X protein) is a multifunc-
tional regulator of cellular signal transduction and
transcription pathways in host-infected cells. Evidence
suggests that HBx has a critical role in the pathogene-
sis of hepatocellular carcinoma. However, the lack
of efﬁcient large-scale preparation methods for
soluble HBx has hindered studies on the structure
and function of HBx. Here, a new pMAL-c2x protein
fusion and puriﬁcation system was used for high-level
expression of soluble HBx fusion protein. The high-
purity fusion protein was obtained via amylose resin
chromatography and Q-Sepharose chromatography.
The untagged HBx was efﬁciently and rapidly puriﬁed
by Sephadex G-75 chromatography after cleavage by
Factor Xa at 23◦C. The purity of active HBx protein
was >99% with a very stable secondary structure domi-
nated by α-helix, β-sheet and random structure. The
puriﬁed HBx protein can be analysed to determine its
crystal structure and function and its capabilities as an
effective immunogen.
Introduction
Chronic infection with HBV (hepatitis B virus) is one of the
major causes of HCC (hepatocellular carcinoma), and HBV-
related HCC is among the top ten most common cancers
worldwide. At present, approx. 400 million people suffer
from chronic HBV infection, ensuring HBV’s continued
role as a major challenge to human health [1,2]. Although
the pathogenesis of HBV-related HCC has not been fully
described, evidence suggests that HBx (HBV X protein)
plays a crucial role [3].
HBx is a multifunctional regulator that modulates
transcription, signal transduction, cell-cycle progress,
proteindegradationpathways,apoptosisandgeneticstability
by directly or indirectly interacting with host factors [4].
Host proteins interacting with HBx are divided into three
groups. The ﬁrst group comprises intranuclear proteins,
including general TFs (transcription factors), such as TFIIB,
TFIIH, TFIIF, p120E4F and p53 and numerous specialized TFs
[5–12].ThesecondgroupconsistsofDNAinjuryandrepair-
related proteins. HBx interferes with normal DNA repair by
competitively binding to the DDB1 (damage-speciﬁc DNA
binding protein 1) [13–15]. The third group is made up of
intracytoplasmic proteins involved in the progress of signal
transduction. HBx interacts with Pin1, the peptidylprolyl
cis–trans isomerase that plays a critical role in normal
signal-transduction-mediated cell functions, to accelerate
hepatocarcinogenesis [16,17]. Moreover, HBx can impact
the signal transduction pathway by binding with the SH3
(Src homology 3) motif of Rac1 to boost the replication
of HBV in the hepatocytes [18]. HBx has also been shown
to participate in host programmed cell death through
i t si n t e r a c t i o n sw i t hc F L I P{cellular FLICE [FADD (Fas-
associated death domain)-like interleukin 1β-converting
enzyme]-inhibitory protein} [19]. Taking these observations
together, HBx is considered to be essential for maintaining
HBV replication and has been implicated in the development
of HCC in chronically infected patients.
Large-scale preparation of soluble HBx protein can
provide a basis for detailed structural and functional
studies and ultimately improve our understanding of HBx
pathogenesis. However, previous attempts at large-scale
production remain wholly ineffective. Use of Escherichia
coli for growth and puriﬁcation resulted in the whole
HBx protein and/or a truncated version to be expressed
in inclusion-body form [20–22]. Likewise, when HBx
was expressed in a baculovirus system, cell fractionation
experiments revealed that only a minor part of HBx was
produced in a soluble form and most of the protein
formed intracellular aggregates [23]. Analysis of ESI-MS
(electrospray ionization MS) revealed that renatured HBx
has only three disulﬁdes, and it retains some functional
properties, such as binding to RNA and p53 protein. This
suggested that after denaturation and renaturation, the
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higher structure of HBx protein might be partially affected,
whereas its primary structure remains intact. In the present
study, a new pMAL-c2x fusion protein and puriﬁcation
system was developed for high-level expression of soluble
HBx fusion protein without denaturation or renaturation.
Moreover, in this system, HBx protein is completely
expressed without any vector-derived amino acids at the
N-terminus. This system will allow future research studies
to determine the crystal structure of puriﬁed HBx protein.
Materials and methods
Reagents and supplies
Restriction enzymes and T4 DNA ligase were obtained
from TaKaRa. Protein standards for molecular-mass
determination, Xa protease and pMAL-c2x plasmid vector
were purchased from New England Biolabs. Analytical-grade
chemicals were purchased from Sigma.
Plasmid construction
The coding region of the HBx gene was derived from the
plasmid pCR-XL-TOPO-HBV and cloned into the XmnI
and HindIII restriction sites of the fusion-expression vector
pMAL-c2x (NEB), to construct the pMAL-HBx recombinant
plasmid. The sequences of primers P1 and P2 are 5
 -AT-
GGCTGCTAGGCTGTGCTGC-3
  and 5
 -CCCAAGCTTT-
TAGGCAGAGGTGAAAAAG-3
  respectively. HBx protein
was veriﬁed for complete expression without any vector-
derived amino acids at the N-terminus.
Expression and puriﬁcation of fusion protein
The E. coli strain JM109 was transformed with the pMAL-
HBx recombinant plasmid and grown overnight in LB
(Luria–Bertani) broth plus 100 g/ml ampicillin at 37◦C. The
overnight culture was diluted 1:100 in fresh LB broth+
ampicillin and grown at 37◦Ct oaD600 (attenuance at
600 nm) of 0.6–0.7 and expression was induced with the
addition of 0.03 mM IPTG (isopropyl β-D-thiogalactoside)
for 2.5 h at 37 ◦C. Bacteria were harvested by centrifugation
at 4000 g for 10 min at 4◦C and the bacterial pellets were
suspendedincolumnbuffer[20 mlof1.0 MTris/HCl,pH 7.4,
11.7 g of NaCl, 2.0 ml of 0.5 M EDTA and 154 mg of DTT
(dithiothreitol)]. The overnight culture stored at −20◦C
was thawed in cold water. Sonication was performed using
an Ultra Cell
TM (Sonics and Materials) at an output control
of 25 W by continuous pulses (interstimulus interval: 10 s),
interrupted by 5 s breaks on ice, with a 10 mm probe. The
soluble and insoluble fractions of the E. coli lysate were
separated by centrifugation at 12000 g for 15 min at
4◦C. A total of 15 litres of cultured bacteria was used to
collect the precipitate and purify ∼60 mg/ml fusion protein
using sonication, centrifugation, an afﬁnity column and an
ion-exchange column.
Factor Xa cleavage of fusion protein
The fusion protein was digested with Factor Xa in vitro at
1.0 mg/ml, using a substrate-to-enzyme ratio of 2% (w/w)
for increasing periods of time (12, 24, 48 and 72 h) at 23◦C.
The cleavage reaction with Xa protease was carried out in
deionized distilled water at pH 8.0.
Separation of fusion partner
The cleaved protein mixture was diluted with an equal
volume of deionized distilled water and dialysed against
20 mM Tris/HCl, 25 mM NaCl, 0.5 M urea and 0.05% SDS
(pH 9.5). The viral proteins were separated from the MBP
(maltose-binding protein) partner on a Sephadex G-75
column (Amersham Biosciences), by using an FPLC system
(Amersham Biosciences). The separated HBx protein was
diluted with an equal volume of deionized distilled water.
SDS/PAGE and Western blotting
SDS/PAGE was used to analyse recombinant protein expres-
sion, the rate of protein puriﬁcation and the proteolytic
products of the MBP–HBx fusion protein after Xa protease
treatment. Products were visualized via Coomassie
Brilliant Blue staining. Western-blot experiments were
carried out using polyclonal antibodies (Abcam) generated
against recombinant HBx antigen and anti-rabbit IgG–
HRP (horseradish peroxidase) as primary and secondary
antibodies respectively. Visualization was performed with
DAB ·4HCl (diaminobenzidine tetrahydrochloride) staining.
In vitro activity assay of HBx protein
MBP–HBx, HBx protein or control extract (protein
concentration: 100 μg/ml) was added to 2 ml of DMEM
(Dulbecco’s modiﬁed Eagle’s medium) containing 10% (v/v)
FBS (fetal bovine serum), and then overlaid on a monolayer
of LTR3CAT cells. After 6 h at 37◦C, 8 ml of fresh DMEM
with 10% FBS was added and the cells were harvested for
the CAT (chloramphenicol acetyltransferase) enzyme assay
[20] (Promega) after another 24 h.
CD analysis
CD spectra were scanned at the far-UV range (250–
190 nm) with a CD spectropolarimeter (J-715; Jasco, Tokyo,
Japan) in a 0.1-cm-pathlength quartz CD cuvette at 25◦C.
Protein concentration for the CD analysis was 50 μg/ml;
50 mM phosphate buffer (pH 6.5) was used to dissolve
HBx protein. The values of scan rate, response, bandwidth
and step resolution were 100 nm/min, 0.25 s, 1.0 nm and
0.2 nm respectively. Five scans were averaged to obtain
one spectrum. The CD results were expressed in terms of
mean molar ellipticity [θ] (degrees · cm
2 · dmol
−1).
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Figure 1 Electrophoretic analysis of the expression of pMBP-HBx
recombinant plasmid in E. coli
Proteins were separated by SDS/10% PAGE and stained with Coomassie
Brilliant Blue. Lane 1, uninduced JM109 cells harbouring the recombinant
plasmid; lane 2, induced JM109 cells harbouring the recombinant plasmid after
1 h; lane 3, induced JM109 cells harbouring the recombinant plasmid after 2 h;
lane 4, induced JM109 cells harbouring the recombinant plasmid after 3 h; lane
5, supernatant after sonication of the JM109 cells expressing MBP–HBx; lane
6, inclusion bodies. Lane M contains molecular-mass markers.
Results and discussion
Expression of MBP–HBx fusion protein
Up to 52% of the amino acids in the HBx protein are
hydrophobic and the protein contains four disulﬁde bonds in
a unique arrangement [22]. These structural characteristics
may increase HBx protein’s tendency towards intermolecu-
lar aggregation, improper folding and accumulation in the
inclusion-body fraction. In order to study the crystal
structure of HBx protein, we have used an efﬁcient E. coli
expression system to produce soluble HBx antigen in large
quantities. pMAL-c2x vector is a powerful system for the
expression of soluble proteins in E. coli because the pMAL-
c2x vector has an MBP tag, which can increase the solubility
oftargetproteins.TheHBxgenewasinsertedintotheXmnI
site directly behind a Factor Xa cleavage site, which allowed
HBx protein expression without any amino acid from the
pMAL-c2x vector to remain after cleavage. The HBx protein
was efﬁciently expressed in E. coli cells harbouring the
pMBP-HBx recombinant plasmid as a fusion protein with
MBP (Figure 1). As can be seen in Figure 1, lane 4, the
MBP–HBx fusion protein with a molecular mass of approx.
59 kDa is detected as approx. 15% of the total bacterial cell
proteins, and more than 90% of the protein can be found
in the soluble fraction of the cell lysate (Figure 1, lane 5).
Some attempts have been made to increase the quantity of
the soluble form of the MBP–HBx protein (including lower
incubation temperature for induction, mild disruption of
the cells to avoid denaturation and aggregation of proteins,
and use of detergent and thiol-group-containing reagent
for solubilization), but none resulted in substantially in-
creased solubility of the recombinant proteins.
Puriﬁcation of MBP–HBx fusion protein by amylose
resin chromatography and Q-Sepharose
chromatography
An induced protein band of ∼59 kDa was observed by SDS/
PAGE (Figure 1, lanes 2–4) analysis of JM109 cells harbouring
pMBP-HBx induced with 0.03 mM IPTG. After lysing
the cells by sonication, the MBP–HBx protein primarily
remained in the soluble fraction (∼90%). The proteins were
puriﬁed via amylose resin chromatography under speciﬁc
conditions, yielding 40 ml of high-concentration (2 mg/ml)
protein solutions (Figure 2A). Two protein bands represent-
ing fusion protein of ∼59 kDa and MBP of ∼42 kDa were
observed by SDS/PAGE (Figure 2B). Correspondingly, two
peaks were detected after puriﬁcation via Q-Sepharose
chromatography (Figure 3A) and each was conﬁrmed by
electrophoretic analysis (Figure 3B), suggesting that the HBx
fusion protein was at least partially degraded in E. coli cells.
Figure 2 Puriﬁcation of target protein by amylose resin chromatography
Proteins were separated by SDS/12% PAGE and stained with Coomassie Brilliant Blue. (A) Target protein was separated by amylose resin chromatography. The
leftmost 16 peaks represent non-puriﬁed proteins in the bacterial lysate. Peak 17 on the far right represents the elution protein. Abs 280, A280.( B) Electrophoretic
analysis of the elution protein, including fusion protein of ∼59 kDa and MBP of ∼42 kDa.
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Figure 3 Puriﬁcation of MBP and MBP–HBx by Q-Sepharose chromatography
Proteins were separated by SDS/12% PAGE and stained with Coomassie Brilliant Blue. (A) MBP and MBP–HBx were separated by Q-Sepharose chromatography.
Abs 280, A280; Cond, condition of iron exchange; mAU, milli-absorbance units. (B) Electrophoretic analysis of separated MBP and MBP–HBx (lane 1, MBP; lane 2,
MBP–HBx).
Figure 4 Cleavage of MBP–HBx fusion protein by Factor Xa
Proteins were separated by SDS/15% PAGE and stained with Coomassie
Brilliant Blue. Lanes 1–4, cleavage products after 12, 24, 48 and 72 h.
The concentration of the recombinant puriﬁed MBP–HBx
protein in column buffer was determined and the puriﬁed
protein was used in the UV cross-linking assay [24]. As
a result of the selective solubilization, ∼60 mg of soluble
fusion protein was obtained from 15 litres of culture.
Cleavage of MBP–HBx fusion protein by Factor Xa
Cleavage with Factor Xa was carried out at a w/w ratio
of 2% of fusion protein (e.g. 100 mg of fusion protein
containing 2 mg of Factor Xa). Incubation of the fusion
protein with Factor Xa demonstrated that the amount of
the fusion protein decreases with time, concomitant with
the appearance of cleavage products corresponding to MBP
and HBx (Figure 4). Xa cleavage of the fusion protein was
efﬁcient and quantiﬁable after incubation for 48 h. The
quality and quantity of the cleaved products did not change
Figure 5 Western-blot analysis of puriﬁed MBP–HBx and HBx
Lane 1, puriﬁed MBP–HBx; lane 2, MBP–HBx cleaved by Factor Xa protease.
even after a 72 h incubation period. The advantageous
conformation of the MBP–HBx fusion protein was reﬂected
by the fact that the enzymatic reaction was mainly executed
after a 48 h incubation period at 23◦C. The identity of
the protein bands was conﬁrmed by immunoblotting with
anti-HBx rabbit serum (Figure 5) The cleaved HBx protein
has no residual amino acids from the pMAL-c2x vector.
This is advantageous for performing studies regarding the
structure and function of HBx protein.
Separation of HBx protein from the fusion partner
after cleavage by Factor Xa protease
After fusion protein cleavage by Factor Xa at 23◦C for 48 h,
the solution became semi-opaque. Samples were subjected
to centrifugation at 30000 g for 20 min at 4◦Ca n dt h e
resulting supernatant and pellet were analysed by SDS/
PAGE. Results showed that partial HBx was aggregated
in the pellet. To overcome this problem, we dialysed the
fusion protein cleavage mixture against 20 mM Tris/HCl,
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Figure 6 SDS/PAGE analysis of MBP and HBx separated by Sephadex G-75 chromatography
Proteins were separated by SDS/15% PAGE and stained with Coomassie Brilliant Blue. (A) MBP and HBx separated by Sephadex G-75 chromatography.
(B) Electrophoretic analysis of separated MBP and HBx (lane 1, HBx; lane 2, MBP). Abs 280, A280; mAU, milli-absorbance units.
25 mM NaCl, 0.5 M urea and 0.05% SDS (pH 9.5) at 4◦C.
This method is known to increase the solubility of HBx
protein while avoiding denaturation processes [25]. After
dialysis, the solution appeared clear. Since the experimental
approach involving afﬁnity puriﬁcation of the cleaved MBP–
HBx fusion protein was ineffective, we chose to separate
the cleaved proteins according to their molecular masses.
Cleaved MBP and HBx were separated on a Sephadex G-75
column (Figure 6A). The ﬁrst chromatography run resulted
in an efﬁcient separation. Peak fractions were analysed for
their purity by means of SDS/PAGE (Figure 6B). The two
peaks shown in Figure 6(B) (lanes 1 and 2) represent those
fractions primarily containing MBP and HBx at a purity of
>99%. Using the above-outlined conditions, we obtained
approx. 10 mg of recombinant HBx proteins.
In vitro activity assay of HBx protein
Previous studies have demonstrated that HBx protein from
E. coli possesses biological activity [20]. A known function of
HBx protein is trans-activation of particular cis-acting regu-
latoryelements;ofthese,theHIVLTR(longterminalrepeat)
is the most comprehensively characterized. Thus we em-
ployed a HeLa cell-derived line (LTR3CAT) stably transfec-
ted with a plasmid containing the bacterial gene for CAT un-
der the control of the HIV LTR sequences. This assay system
has been described previously to directly measure cellular
uptake of proteins [26]. Figure 7 shows the results obtained
for CAT gene expression in the LTR3CAT cell line after
overlay with DMEM, control extracts, MBP–HBx and HBx
at a protein concentration of 100 μg/ml. Background CAT
activity was detected in all lanes, albeit at a minimal amount
(Figure 7, lane 1). Increases in CAT activity were clear in the
MBP–HBx and HBx protein overlay lanes (Figure 7, lanes 3
and 4) compared with control extracts (Figure 7, lane 2).
This level of stimulation by HBx is consistent with the results
Figure 7 Functional activity of HBx protein
Lanes 1–4, cells overlaid with DMEM, control extracts, MBP–HBx and HBx
at a protein concentration of 100 μg/ml respectively. Fold stimulation of
CAT activity over the background is indicated (see the main text). Cm,
chloramphenicol; bCm, butyrylated chloramphenicol.
obtained by others after DNA transfection [27]. Thus the
HBx protein produced in E. coli was biologically active.
Previous ﬁndings indicated that HBx protein cannot
bind directly with DNA sequences [28]. One possible
mechanism to explain the trans-activating capabilities of
the HBx protein in the absence of a DNA-binding function
involves the HBx protein interacting with, or modifying,
other TFs to indirectly activate transcription. For example,
it has been conﬁrmed recently that HBx can directly bind
the VBP1 (von Hippel–Lindau-binding protein 1) TF to
activate NF-κB (nuclear factor κB) gene transcription [29].
CD spectra of HBx protein
The far-UV CD spectra of a protein are a direct reﬂection
of its secondary structure. Figure 8 shows the CD spectrum
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Figure 8 Far-UV CD spectrum of puriﬁed HBx protein
ofpuriﬁedHBxprotein.ThespectraofHBxproteinrevealed
one strong positive peak in the vicinity of 194 nm, one
negative shoulder at 218 nm, two negative troughs at 207
and 222 nm and one weak positive peak between 220 and
230 nm. The positive peak at 194 nm and negative shoulder
at 218 nm are both indicative of the presence of β-sheet
structure(s). The two negative troughs are caused by a neg-
ative Cotton effect characteristic of α-helical structure(s),
and the weak positive peak between 220 and 230 nm is char-
acteristic of a disordered protein structure [30]. The results
obtained from the CD spectra analysis revealed that the sec-
ondary structure of HBx protein was composed of three dif-
ferent conformations including α-helix, β-sheet and random
structure. This suggested that puriﬁed HBx protein in the
absence of denaturation or renaturation processes remains
a stable secondary structure in 50 mM phosphate buffer
(pH 6.5) at 25◦C. Thus the puriﬁed HBx protein can be used
for further analysis of its crystal structure and may form the
correct crystal structure more easily under this condition.
We have described here a feasible E. coli-based method
for high-throughput production and puriﬁcation of recom-
binantMBP–HBxprotein,amethodthatcanyieldanefﬁcient
separation of protein fusion partners. Furthermore, the
resultantsolubleHBxproteinwasobtainedwithoutdenatur-
ation or renaturation processes on a preparative scale. This
procedure will beneﬁt future studies that aim to determine
the structure and function of HBx protein and will probably
be helpful for the efforts to understand HBV pathogenesis.
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